Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo

Kayiba, N.K.; Yobi, D.M.; Tchakounang, V.R.K.; Mvumbi, D.M.; Kabututu, P.Z.; Devleesschauwer, B.; Mukomena, E.S.; De Mol, Patrick; Hayette, Marie-Pierre; Mvumbi, G.L.; Rosas-Aguirre, A.; Lusamba, P.D.; Speybroeck, N.

doi:10.1016/j.meegid.2021.105009

Article (Scientific journals)

Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo

Kayiba, N.K.; Yobi, D.M.; Tchakounang, V.R.K. et al.

2021 • In Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases, 94

Peer reviewed

Permalink
https://hdl.handle.net/2268/295902

DOI
10.1016/j.meegid.2021.105009

PubMed
34284138

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

4.pdf

Author postprint (554.18 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Democratic Republic of Congo; Intermittent preventive treatment in pregnancy; Laboring woman; Malaria; Resistance; Sulfadoxine-Pyrimethamine; pyrimethamine plus sulfadoxine; antimalarial agent; fanasil, pyrimethamine drug combination; pyrimethamine; sulfadoxine; allogeneic stem cell transplantation; amenorrhea; anemia; Article; blood smear; controlled study; cross-sectional study; DNA extraction; dried blood spot testing; feasibility study; female; fetus death; fever; genotype; gestational age; hemoglobin blood level; human; low birth weight; major clinical study; malaria; malaria falciparum; microscopy; nested polymerase chain reaction; neutrophil count; newborn; outcome assessment; parasite clearance; Plasmodium falciparum; polymerase chain reaction restriction fragment length polymorphism; pregnancy; pregnancy diabetes mellitus; pregnancy outcome; prophylaxis; protein expression; questionnaire; real time polymerase chain reaction; restriction fragment length polymorphism; twin pregnancy; adolescent; adult; Democratic Republic Congo; drug combination; drug resistance; hospital; parasitology; pregnancy complication; young adult; Adolescent; Adult; Antimalarials; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Female; Hospitals; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine; Young Adult

Abstract :

[en] Background: Increasing resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine (SP) threatens its usefulness for intermittent preventive treatment in pregnancy (IPTp-SP). The prophylactic effects of IPTp-SP on maternal malaria and adverse pregnancy outcomes were evaluated in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo (DRC). Methods: Laboring women (n = 844) and respective newborns were investigated. Blood samples collected from women were tested for malaria using rapid diagnostic test (RDT), blood smears examination, and real-time PCR. The hemoglobin level was measured by HemoCue© analyzer. A PCR-RFLP method was applied for detecting N51I, C59R, and S108N mutations on dhfr along with A437G and K540E mutations on dhps in P. falciparum positive samples. Logistic regression models assessed relationships between IPTp-SP uptake and pregnancy outcomes. Results: P. falciparum malaria was detected at delivery in 10.8% of women and was statistically associated with fever during the pregnancy (OR = 2.9 [1.5; 6.3]; p = 0.004) and maternal anemia (OR = 3.9 [2.4; 6.3]; p < 0.001). One out of five parasites was a quintuple mutant encoding dhfr mutations 51I, 59R, and 108 N along with dhps mutations 437G and 540E. The molecular profile of parasites (i.e., 32.6% of parasites carrying dhps K540E) was suitable with continued use of SP for IPTp. IPTp-SP uptake was not associated with reduced maternal malaria, fever reported in pregnancy, or fetal deaths (p > 0.05). Conversely, three or more doses of SP were associated with reduced maternal anemia at delivery (OR = 0.4 [0.2; 0.9]; p = 0.024), shortened gestation (OR = 0.4 [0.2; 0.8]; p = 0.009), and low-birth weights (OR = 0.2 [0.1; 0.5]; p < 0.001). Conclusion: IPTp-SP was not associated with reduced maternal malaria in our study, but evidence was found of a prophylactic effect against adverse pregnancy outcomes. To counteract further loss of clinical effects of IPTp-SP in the study population, alternative strategies able to improve its anti-malarial efficacy such as combination of SP with partner molecules should be implemented. © 2021

Disciplines :

Laboratory medicine & medical technology

Author, co-author :

Kayiba, N.K.; Research Institute of Health and Society, Catholic University of Louvain, Brussels, 1200, Belgium, School of Public Health, Faculty of Medicine, University of Kinshasa, Kinshasa XI, 127, Democratic Republic Congo, Department of Public Health, Faculty of Medicine, University of Mbujimayi, 225 Mbujimayi, Democratic Republic Congo

Yobi, D.M.; Department of Basic Sciences, Faculty of Medicine, University of Kinshasa, Kinshasa XI, 127, Democratic Republic Congo

Tchakounang, V.R.K.; Laboratory of Clinical Microbiology, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, 4000, Belgium

Mvumbi, D.M.; Department of Basic Sciences, Faculty of Medicine, University of Kinshasa, Kinshasa XI, 127, Democratic Republic Congo, Department of Quality of Laboratories, Sciensano, Brussels, 1050, Belgium

Kabututu, P.Z.; Department of Basic Sciences, Faculty of Medicine, University of Kinshasa, Kinshasa XI, 127, Democratic Republic Congo

Devleesschauwer, B.; Department of Epidemiology and Public Health, Sciensano, Brussels, 1050, Belgium, Department of Veterinary Public Health and Food Safety, Ghent University, Merelbeke, B-9820, Belgium

Mukomena, E.S.; National Malaria Control Program, National Ministry of Public Health, Democratic Republic Congo, Department of Public Health, Faculty of Medicine, University of Lubumbashi, Lubumbashi, 1825, Democratic Republic Congo

De Mol, Patrick ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques

Hayette, Marie-Pierre ; Centre Hospitalier Universitaire de Liège - CHU > > Service de microbiologie clinique

Mvumbi, G.L.; Department of Basic Sciences, Faculty of Medicine, University of Kinshasa, Kinshasa XI, 127, Democratic Republic Congo

More authors (3 more)

Language :

English

Title :

Publication date :

2021

Journal title :

Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases

ISSN :

1567-1348

eISSN :

1567-7257

Publisher :

Elsevier B.V.

Volume :

Peer reviewed :

Peer reviewed

Funding text :

This work was supported by the Belgian Cooperation Agency through the Académie de Recherche et d'Enseignement Supérieur (ARES) .

Available on ORBi :

since 21 October 2022

Statistics

Number of views

48 (0 by ULiège)

Number of downloads

130 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Alker, A.P., Kazadi, W.M., Kutelemeni, A.K., Bloland, P.B., Tshefu, A.K., Meshnick, S.R., dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo. Tropical Med. Int. Health 13 (2008), 1384–1391.
Baker, J., McCarthy, J., Gatton, M., Kyle, D.E., Belizario, V., Luchavez, J., Bell, D., Cheng, Q., Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J. Infect. Dis. 192 (2005), 870–877.
Baraka, V., Delgado-Ratto, C., Nag, S., Ishengoma, D.S., Madebe, R.A., Mavoko, H.M., Nabasumba, C., Lutumba, P., Alifrangis, M., Van Geertruyden, J.-P., Different origin and dispersal of sulfadoxine-resistant Plasmodium falciparum haplotypes between eastern Africa and Democratic Republic of Congo. Int. J. Antimicrob. Agents 49 (2017), 456–464.
Botto, L.D., Panichello, J.D., Browne, M.L., Krikov, S., Feldkamp, M.L., Lammer, E., Shaw, G.M., Study, N.B.D.P, Congenital heart defects after maternal fever. Am. J. Obstet. Gynecol., 210, 2014 359. e351-359. e311.
Capan, M., Mombo-Ngoma, G., Makristathis, A., Ramharter, M., Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin. Malar. J., 9, 2010, 303.
Chico, R.M., Chaponda, E.B., Ariti, C., Chandramohan, D., Sulfadoxine-pyrimethamine exhibits dose-response protection against adverse birth outcomes related to malaria and sexually transmitted and reproductive tract infections. Clin. Infect. Dis. 64 (2017), 1043–1051.
Church, J.A., Fitzgerald, F., Walker, A.S., Gibb, D.M., Prendergast, A.J., The expanding role of co-trimoxazole in developing countries. Lancet Infect. Dis. 15 (2015), 327–339.
Cnops, L., Jacobs, J., Van Esbroeck, M., Validation of a four-primer real-time PCR as a diagnostic tool for single and mixed Plasmodium infections. Clin. Microbiol. Infect. 17 (2011), 1101–1107.
Cohee, L.M., Kalilani-Phiri, L., Boudova, S., Joshi, S., Mukadam, R., Seydel, K.B., Mawindo, P., Thesing, P., Kamiza, S., Makwakwa, K., Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment. Malar. J., 13, 2014, 274.
Dalrymple, U., Arambepola, R., Gething, P.W., Cameron, E., How long do rapid diagnostic tests remain positive after anti-malarial treatment?. Malar. J. 17 (2018), 1–13.
De Beaudrap, P., Turyakira, E., White, L.J., Nabasumba, C., Tumwebaze, B., Muehlenbachs, A., Guérin, P.J., Boum, Y., McGready, R., Piola, P., Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospectivecohort with intensive malaria screening and prompt treatment. Malar. J., 12, 2013, 139.
De Kock, M., Tarning, J., Workman, L., Nyunt, M., Adam, I., Barnes, K., Denti, P., Pharmacokinetics of sulfadoxine and pyrimethamine for intermittent preventive treatment of malaria during pregnancy and after delivery. CPT Pharmacometrics Syst. Pharmacol. 6 (2017), 430–438.
Deloron, P., Bertin, G., Briand, V., Massougbodji, A., Cot, M., Sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy. Emerg. Infect. Dis., 16, 2010, 1666.
Desai, M., Gutman, J., Taylor, S.M., Wiegand, R.E., Khairallah, C., Kayentao, K., Ouma, P., Coulibaly, S.O., Kalilani, L., Mace, K.E., Arinaitwe, E., Mathanga, D.P., Doumbo, O., Otieno, K., Edgar, D., Chaluluka, E., Kamuliwo, M., Ades, V., Skarbinski, J., Shi, Y.P., Magnussen, P., Meshnick, S., Ter Kuile, F.O., Impact of Sulfadoxine-Pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clin. Infect. Dis. 62 (2016), 323–333.
Desai, M., Hill, J., Fernandes, S., Walker, P., Pell, C., Gutman, J., Kayentao, K., Gonzalez, R., Webster, J., Greenwood, B., Prevention of malaria in pregnancy. Lancet Infect. Dis. 18 (2018), e119–e132.
Divala, T.H., Mungwira, R.G., Laufer, M.K., Moving targets: the challenges of studying infectious diseases among pregnant women in resource limited settings. Vaccine 33 (2015), 6401–6405.
Duraisingh, M.T., Curtis, J., Warhurst, D.C., Plasmodium falciparum: detection of polymorphisms in theDihydrofolate ReductaseandDihydropteroate SynthetaseGenes by PCR and restriction digestion. Exp. Parasitol. 89 (1998), 1–8.
Eisele, T.P., Larsen, D.A., Anglewicz, P.A., Keating, J., Yukich, J., Bennett, A., Hutchinson, P., Steketee, R.W., Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect. Dis. 12 (2012), 942–949.
Fried, M., Duffy, P.E., Malaria during pregnancy. Cold Spring Harbor Perspect. Med., 7, 2017, a025551.
Gamboa, D., Ho, M.-F., Bendezu, J., Torres, K., Chiodini, P.L., Barnwell, J.W., Incardona, S., Perkins, M., Bell, D., McCarthy, J., A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One, 5, 2010, e8091.
Gosling, R.D., Gesase, S., Mosha, J.F., Carneiro, I., Hashim, R., Lemnge, M., Mosha, F.W., Greenwood, B., Chandramohan, D., Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet 374 (2009), 1521–1532.
Graham, J.M. Jr., Edwards, M.J., Teratogen update: gestational effects of maternal hyperthermia due to febrile illnesses and resultant patterns of defects in humans. Teratology 58 (1998), 209–221.
Grüner, N., Stambouli, O., Ross, R.S., Dried blood spots-preparing and processing for use in immunoassays and in molecular techniques. J. Vis. Exp., 97, 2015, 52619.
Harrington, W.E., Mutabingwa, T.K., Kabyemela, E., Fried, M., Duffy, P.E., Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin. Infect. Dis. 53 (2011), 224–230.
Kalilani-Phiri, L., Thesing, P.C., Nyirenda, O.M., Mawindo, P., Madanitsa, M., Membe, G., Wylie, B., Masonbrink, A., Makwakwa, K., Kamiza, S., Timing of malaria infection during pregnancy has characteristic maternal, infant and placental outcomes. PLoS One, 8, 2013, e74643.
Kapisi, J., Kakuru, A., Jagannathan, P., Muhindo, M.K., Natureeba, P., Awori, P., Nakalembe, M., Ssekitoleko, R., Olwoch, P., Ategeka, J., Nayebare, P., Clark, T.D., Rizzuto, G., Muehlenbachs, A., Havlir, D.V., Kamya, M.R., Dorsey, G., Gaw, S.L., Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes. Malar. J., 16, 2017, 400.
Kern, S.E., Tiono, A.B., Makanga, M., Gbadoé, A.D., Premji, Z., Gaye, O., Sagara, I., Ubben, D., Cousin, M., Oladiran, F., Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis. Malar. J., 10, 2011, 210.
Kozycki, C.T., Umulisa, N., Rulisa, S., Mwikarago, E.I., Musabyimana, J.P., Habimana, J.P., Karema, C., Krogstad, D.J., False-negative malaria rapid diagnostic tests in Rwanda: impact of Plasmodium falciparum isolates lacking hrp2 and declining malaria transmission. Malar. J., 16, 2017, 123.
Le Gouez, A., Benachi, A., Mercier, F.J., Fever and pregnancy. Anaesth. Critic. Care Pain Med. 35 (2016), S5–S12.
Likwela, J.L., Lutte antipaludique en République Démocratique du Congo à l'approche de l’échéance des OMD : progrès, défis et perspectives [Éditorial]. Rev. méd. Gd. Lacs 3 (2014), 149–155.
Likwela, J.L., D'Alessandro, U., Lokwa, B.L., Meuris, S., Dramaix, M.W., Sulfadoxine–pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC). Tropical Med. Int. Health 17 (2012), 322–329.
Mandoko, N.P., Rouvier, F., Matendo Kakina, L., Moke Mbongi, D., Latour, C., Losimba Likwela, J., Ngoyi Mumba, D., Bi Shamamba, S.K., Tamfum Muyembe, J.-J., Muepu Tshilolo, L., Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles. J. Antimicrob. Chemother. 73 (2018), 2704–2715.
Mayor, A., Moro, L., Aguilar, R., Bardají, A., Cisteró, P., Serra-Casas, E., Sigaúque, B., Alonso, P.L., Ordi, J., Menéndez, C., How hidden can malaria be in pregnant women? Diagnosis by microscopy, placental histology, polymerase chain reaction and detection of histidine-rich protein 2 in plasma. Clin. Infect. Dis. 54 (2012), 1561–1568.
McGready, R., Nosten, F., Proxies and prevention of malaria in pregnancy. Lancet Infect. Dis. 12 (2012), 902–903.
Menard, D., Dondorp, A., Antimalarial drug resistance: a threat to malaria elimination. Cold Spring Harbor Perspect. Med., 7, 2017, a025619.
Minja, D.T., Schmiegelow, C., Mmbando, B., Boström, S., Oesterholt, M., Magistrado, P., Pehrson, C., John, D., Salanti, A., Luty, A.J., Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania. Emerg. Infect. Dis., 19, 2013, 1446.
Mobula, L., Lilley, B., Tshefu, A.K., Rosenthal, P.J., Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo. Am. J. Trop. Med. Hygiene 80 (2009), 555–558.
Molina-Cruz, A., DeJong, R.J., Ortega, C., Haile, A., Abban, E., Rodrigues, J., Jaramillo-Gutierrez, G., Barillas-Mury, C., Some strains of Plasmodium falciparum, a human malaria parasite, evade the complement-like system of Anopheles gambiae mosquitoes. Proc. Natl. Acad. Sci. 109 (2012), E1957–E1962.
More, V., Fever in pregnancy and its maternal and fetal outcomes. Int. J. Reprod. Contracept Obstet. Gynecol. 6 (2017), 5523–5527.
MPSMRM, MSP, ICF International, Enquête Démographique et de Santé en République Démocratique du Congo 2013–2014 : Rapport de synthèse. Ministère du Plan et Suivi de la Mise en oeuvre de la Révolution de la Modernité (MPSMRM). 2014, Ministère de la Santé Publique (MSP) et ICF International, Rockville, Maryland, USA.
Naidoo, I., Roper, C., Mapping ‘partially resistant’,‘fully resistant’, and ‘super resistant'malaria. Trends Parasitol. 29 (2013), 505–515.
Nankabirwa, J., Cundill, B., Clarke, S., Kabatereine, N., Rosenthal, P.J., Dorsey, G., Brooker, S., Staedke, S.G., Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren. PLoS One, 5, 2010, e13438.
OMS, Stratégie Technique Mondiale De Lutte Contre Le Paludisme 2016-2030. 2015, Organisation Mondiale de la Santé (OMS), Suisse, Génève.
PMI, Democratic Republic of the Congo. Malaria Operational Plan FY, 2013, Malaria Initiative (PMI), President's.
PNLP, Plan Stratégique National de Communication 2017-2020. Ministère de la Santé Publique. 2017, Programe National de Lutte contre le Paludisme (PNLP), Kinshasa, RD Congo p. 45 pages.
Radeva-Petrova, D., Kayentao, K., ter Kuile, F.O., Sinclair, D., Garner, P., Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment. Cochrane Database Syst. Rev., 2014, 2014, CD000169.
Rahman, M.M., Abe, S.K., Rahman, M.S., Kanda, M., Narita, S., Bilano, V., Ota, E., Gilmour, S., Shibuya, K., Maternal anemia and risk of adverse birth and health outcomes in low-and middle-income countries: systematic review and meta-analysis, 2. Am. J. Clin. Nutr. 103 (2016), 495–504.
Roh, M.E., Ter Kuile, F.O., Rerolle, F., Glymour, M.M., Shiboski, S., Gosling, R., Gutman, J., Kakuru, A., Desai, M., Kajubi, R., Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis. Lancet Glob. Health 8 (2020), e942–e953.
Ruh, E., Bateko, J.P., Imir, T., Taylan-Ozkan, A., Investigation of pregnancy-associated malaria by microscopy, rapid diagnostic test and PCR in Bandundu, the Democratic Republic of Congo. Trans. R. Soc. Trop. Med. Hyg. 112 (2018), 8–13.
Swarthout, T., Van Den Broek, I., Kayembe, G., Montgomery, J., Pota, H., Roper, C., Artesunate+ amodiaquine and artesunate+ sulphadoxine–pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes. Tropical Med. Int. Health 11 (2006), 1503–1511.
ter Kuile, F.O., van Eijk, A.M., Filler, S.J., Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. Jama 297 (2007), 2603–2616.
Tran, E.E., Cheeks, M.L., Kakuru, A., Muhindo, M.K., Natureeba, P., Nakalembe, M., Ategeka, J., Nayebare, P., Kamya, M., Havlir, D., The impact of gravidity, symptomatology and timing of infection on placental malaria. Malar. J. 19 (2020), 1–11.
Uneke, C., Diagnosis of Plasmoduim falciparum malaria in pregnancy in sub-Saharan Africa: the challenges and public health implications. Parasitol. Res. 102 (2008), 333–342.
USAID, The US President's Malaria Initiative in the Democratic Republic of Congo: Malaria Operational Plan FY 2017. 2017.
van Eijk, A.M., Larsen, D.A., Kayentao, K., Koshy, G., Slaughter, D.E., Roper, C., Okell, L.C., Desai, M., Gutman, J., Khairallah, C., Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. Lancet Infect. Dis. 19 (2019), 546–556.
Verity, R., Aydemir, O., Brazeau, N.F., Watson, O.J., Hathaway, N.J., Mwandagalirwa, M.K., Marsh, P.W., Thwai, K., Fulton, T., Denton, M., The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC. Nat. Commun. 11 (2020), 1–10.
Vinayak, S., Alam, M.T., Mixson-Hayden, T., McCollum, A.M., Sem, R., Shah, N.K., Lim, P., Muth, S., Rogers, W.O., Fandeur, T., Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLoS Pathog., 6, 2010, e1000830.
Walker, P.G., ter Kuile, F.O., Garske, T., Menendez, C., Ghani, A.C., Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study. Lancet Glob. Health 2 (2014), e460–e467.
WHO, WHO Evidence Review Group: Intermittent Preventive Treatment of Malaria in Pregnancy (IPTp) with Sulfadoxine-Pyrimethamine (SP). 2012, WHO Geneva.
WHO, WHO Policy Brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulfadoxine-Pyrimethamine (IPTp-SP). 2013, World Health Organization (WHO), Switzerland, Geneva.
WHO, World Malaria Report 2018. 2018, World Health Organization (WHO), Switzerland, Geneva.
Wongsrichanalai, C., Barcus, M.J., Muth, S., Sutamihardja, A., Wernsdorfer, W.H., A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am. J. Trop. Med. Hygiene 77 (2007), 119–127.
Yin, Z., Xu, W., Xu, C., Zhang, S., Zheng, Y., Wang, W., Zhou, B., A population-based case-control study of risk factors for neural tube defects in Shenyang, China. Childs Nerv. Syst. 27 (2011), 149–154.